Left atrial enlargement in the early stage of hypertensive heart disease: A common but ignored condition

Journal of Clinical Hypertension

Volumn 16, Issue 3, 2014, Pages 192-197

  Su, Guanhua ^a   Cao, Heng ^a   Xu, Sudan ^a   Lu, Yongxin ^a   Shuai, Xinxin ^a   Sun, Yufei ^a   Liao, Yuhua ^a   Li, Jingdong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DECELERATION TIME; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRINKING BEHAVIOR; EARLY PEAK VELOCITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FAMILY HISTORY; FEMALE; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART FAILURE WITH NORMAL EJECTION FRACTION; HEART LEFT ATRIUM DIAMETER; HEART LEFT ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE FILLING; HUMAN; LATE PEAK VELOCITY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METABOLIC SYNDROME X; P WAVE; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; FEMALE; HEART ATRIA; HEART DISEASES; HEART FAILURE; HUMANS; HYPERTENSION; HYPERTROPHY; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; STROKE VOLUME;

EID: 84895930777     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12282     Document Type: Article

References (32)

1. Shigematsu Y, Norimatsu S, Ogimoto A, et al. The influence of insulin resistance and obesity on left atrial size in Japanese hypertensive patients. Hypertens Res. 2009;32:500-504.
2. Tsang TS, Barnes ME, Gersh BJ, et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 2002;90:1284-1289.
3. Nicolaou VN, Papadakis JE, Karatzis EN, et al. Impact of the metabolic syndrome on atrial size in patients with new-onset atrial fibrillation. Angiology. 2007;58:21-25.
4. Mancia G, Fagard R, Narkiewicz K, et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31:1925-1938.
5. Liu LS. [2010 Chinese guidelines for the management of hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39:579-615.
6. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28:2745-2749.
7. Hazen MS, Marwick TH, Underwood DA. Diagnostic accuracy of the resting electrocardiogram in detection and estimation of left atrial enlargement: an echocardiographic correlation in 551 patients. Am Heart J. 1991;122:823-828.
8. Munuswamy K, Alpert MA, Martin RH, et al. Sensitivity and specificity of commonly used electrocardiographic criteria for left atrial enlargement determined by M-mode echocardiography. Am J Cardiol. 1984;53:829-832.
9. Lee KS, Appleton CP, Lester SJ, et al. Relation of electrocardiographic criteria for left atrial enlargement to two-dimensional echocardiographic left atrial volume measurements. Am J Cardiol. 2007;99:113-118.
10. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. 1949. Ann Noninvasive Electrocardiol. 2001;6:343-368.
11. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
12. Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28:2539-2550.
13. Gerdts E, Oikarinen L, Palmieri V, et al. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Hypertension. 2002;39:739-743.
14. Cuspidi C, Negri F, Lonati L, et al. Prevalence and correlates of echocardiographic left atrial enlargement in hypertensive outpatients in clinical practice. Clin Exp Hypertens. 2011;33:328-335.
15. Cuspidi C, Rescaldani M, Sala C. Prevalence of echocardiographic left-atrial enlargement in hypertension: a systematic review of recent clinical studies. Am J Hypertens. 2013;26:456-464.
16. Zile MR, Gottdiener JS, Hetzel SJ, et al. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation. 2011;124:2491-2501.
17. Carson P, Massie BM, McKelvie R, et al. The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design. J Card Fail. 2005;11:576-585.
18. Park SM, Park SW, Casaclang-Verzosa G, et al. Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: data from the Acorn trial. Am Heart J. 2009;157:762-710.
19. Ohtani T, Mohammed SF, Yamamoto K, et al. Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fraction. Eur Heart J. 2012;33:1742-1749.
20. Kizer JR, Bella JN, Palmieri V, et al. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J. 2006;151:412-418.
21. Russo C, Jin Z, Homma S, et al. Left atrial minimum volume and reservoir function as correlates of left ventricular diastolic function: impact of left ventricular systolic function. Heart. 2012;98:813-820.
22. Lee JS, Shim CY, Wi J, et al. Left ventricular diastolic function is closely associated with mechanical function of the left atrium in patients with paroxysmal atrial fibrillation. Circ J. 2013;77:697-704.
23. Myung Y, Seo HS, Jung IH, et al. The correlation of carotid artery stiffness with heart function in hypertensive patients. J Cardiovasc Ultrasound. 2012;20:134-139.
24. Edelmann F, Stahrenberg R, Gelbrich G, et al. Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction. Clin Res Cardiol. 2011;100:755-764.
25. Chillo P, Rieck AE, Lwakatare J, et al. Left atrial volume index as a marker of left ventricular diastolic dysfunction in asymptomatic Tanzanian diabetic patients. Blood Press. 2013;22:86-93.
26. Kindermann M. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28:2686; author reply 2686-2687.
27. Uzun M, Koz C, Yildirim M, et al. [Does accompanying metabolic syndrome contribute to heart dimensions in hypertensive patients?]. Turk Kardiyol Dern Ars. 2008;36:446-450.
28. Ayer JG, Almafragy HS, Patel AA, et al. Body mass index is an independent determinant of left atrial size. Heart Lung Circ. 2008;17:19-24.
29. Dzherieva IS, Volkova NI. [Arterial hypertension and metabolic disorders]. Klin Med (Mosk). 2010;88:4-8.
30. Campbell DJ, Somaratne JB, Jenkins AJ, et al. Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease. Cardiovasc Diabetol. 2011;10:80.
31. Tanti JF, Ceppo F, Jager J, et al. Implication of inflammatory signaling pathways in obesity-induced insulin resistance. Front Endocrinol (Lausanne). 2012;3:181.
32. Pellegrino PL, Brunetti ND, De Gennaro L, et al. Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset. Intern Emerg Med. 2013;8:123-128.